Nomograms for predicting survival in patients with gastric carcinoid or neuroendocrine carcinoma based on the SEER database

被引:0
作者
Shi, H. [1 ,2 ]
Sun, S. -Y. [2 ]
Liu, S. -S. [3 ]
Liu, X. -N. [1 ]
He, Y. -S. [1 ]
Peng, Q. [1 ]
机构
[1] Univ South China, Cent Hosp Shaoyang, Dept Gastroenterol, Shaoyang, Hunan, Peoples R China
[2] Jinan Univ, Affiliated Hosp 1, Dept Tradit Chinese Med, Guangzhou, Guangdong, Peoples R China
[3] Univ South China, Dept Pathol, Cent Hosp Shaoyang, Shaoyang, Hunan, Peoples R China
关键词
Gastric neuroendocrine carcinoma; Gastric carcinoid; Nomogram; SEER; Surgery; Chemotherapy; prognosis; TUMORS; CANCER; GUIDELINES; MANAGEMENT; DIAGNOSIS; OUTCOMES;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: The aim of this study was to construct a competent model that can effectively predict the prognosis of patients with gastric carcinoid (GC) or neuroendocrine carcinoma (NEC).PATIENTS AND METHODS: Data of patients with GC or NEC were retrieved from the Surveil-lance, Epidemiology, and End Results (SEER) database from 1975 to 2017. Univariable and multivariable Cox analysis was used to deter-mine the independent factors for patients with GC or NEC. Nomograms were established based on the independent factors and the results were evaluated using receiver operating characteris-tic (ROC) curves, calibration curves, and deci-sion curve analysis (DCA).RESULTS: A total of 214 patients with GC and 65 patients with gastric NEC were extracted from the SEER database. Independent prognostic fac-tors for patients with GC were M stage, gender, age, and chemotherapy. Independent prognos-tic factors for patients with gastric NEC includ-ed age, M stage, and chemotherapy. ROC curves, calibration curves, and DCA confirmed that the nomograms can precisely predict the prognosis of patients with GC and NEC. CONCLUSIONS: The nomograms can effec-tively predict survival in patients with GC or NEC, which may assist the clinician in their de-cision-making and quantitatively judge the prog-nosis of individual patients.
引用
收藏
页码:3071 / 3081
页数:11
相关论文
共 35 条
[1]  
[Anonymous], 2004, NEUROENDOCRINOLOGY
[2]   Chemotherapy [J].
Arnold, R ;
Rinke, A ;
Schmidt, C .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2005, 19 (04) :649-656
[3]   Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors [J].
Basu, Sandip ;
Parghane, Rahul, V ;
Kamaldeep ;
Chakrabarty, Sudipta .
SEMINARS IN NUCLEAR MEDICINE, 2020, 50 (05) :447-464
[4]   Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks [J].
Blanche, Paul ;
Dartigues, Jean-Francois ;
Jacqmin-Gadda, Helene .
STATISTICS IN MEDICINE, 2013, 32 (30) :5381-5397
[5]   Nomogram based on tumor-associated neutrophil-to-lymphocyte ratio to predict survival of patients with gastric neuroendocrine neoplasms [J].
Cao, Long-Long ;
Lu, Jun ;
Lin, Jian-Xian ;
Zheng, Chao-Hui ;
Li, Ping ;
Xie, Jian-Wei ;
Wang, Jia-Bin ;
Chen, Qi-Yue ;
Lin, Mi ;
Tu, Ru-Hong ;
Huang, Chang-Ming .
WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (47) :8376-8386
[6]   Prognostic and predictive biomarkers in neuroendocrine tumours [J].
Chan, David L. ;
Clarke, Stephen J. ;
Diakos, Connie I. ;
Roach, Paul J. ;
Bailey, Dale L. ;
Singh, Simron ;
Pavlakis, Nick .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 113 :268-282
[7]   Progress in the Treatment of Neuroendocrine Tumors [J].
Chan, Jennifer A. ;
Kulke, Matthew H. .
CURRENT ONCOLOGY REPORTS, 2009, 11 (03) :193-199
[8]   Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States [J].
Dasari, Arvind ;
Shen, Chan ;
Halperin, Daniel ;
Zhao, Bo ;
Zhou, Shouhao ;
Xu, Ying ;
Shih, Tina ;
Yao, James C. .
JAMA ONCOLOGY, 2017, 3 (10) :1335-1342
[9]   CANCER Macrophages limit chemotherapy [J].
De Palma, Michele ;
Lewis, Claire E. .
NATURE, 2011, 472 (7343) :303-304
[10]   Endocrine tumours of the stomach [J].
Delle Fave, G ;
Capurso, G ;
Milione, M ;
Panzuto, F .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2005, 19 (05) :659-673